ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 27 filers reported holding ACASTI PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $411,000 | -25.0% | 732,222 | -19.9% | 0.04% | +2.6% |
Q1 2021 | $548,000 | +144.6% | 913,651 | +32.8% | 0.04% | +62.5% |
Q4 2020 | $224,000 | +729.6% | 687,985 | +412.3% | 0.02% | +380.0% |
Q3 2020 | $27,000 | -77.1% | 134,296 | -46.8% | 0.01% | -64.3% |
Q2 2020 | $118,000 | +413.0% | 252,405 | +514.6% | 0.01% | +1300.0% |
Q2 2018 | $23,000 | -17.9% | 41,066 | +47.1% | 0.00% | -50.0% |
Q1 2018 | $28,000 | -79.6% | 27,909 | -80.8% | 0.00% | -71.4% |
Q4 2017 | $137,000 | +389.3% | 145,202 | +633.9% | 0.01% | +600.0% |
Q3 2017 | $28,000 | – | 19,785 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 236,559 | $594,000 | 0.04% |
INTACT INVESTMENT MANAGEMENT INC. | 89,490 | $287,000 | 0.01% |
BANK OF MONTREAL /CAN/ | 210,484 | $537,000 | 0.00% |
DEUTSCHE BANK AG\ | 215 | $0 | 0.00% |
Tower Research Capital LLC (TRC) | 200 | $1,000 | 0.00% |
CITIGROUP INC | 30 | $0 | 0.00% |
MORGAN STANLEY | 18 | $0 | 0.00% |
Renaissance Technologies | 20,900 | $53,000 | 0.00% |
ROYAL BANK OF CANADA | 588 | $1,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 400 | $1,000 | 0.00% |